Member Info for bunsenburner123

Quite easy to solve - once green a code gets sent to a database and it pings bavk a code or barcode, for example. With everything being electronic it’s v easy to certify

Awesome awesome awesome guys. This is the cliff edge of growth. Love that there’s a business model in place post covid with yellow fever, HIV, TB etc with test, track & monitor too

What is Synovate Global?

What’s this mate?

Borris Johnson just mentioned ‘lateral flow tests.’ I say again - The Healgen Test is 1 of 3 lateral flow tests certified by the U.K. government. Will we win part of that tender? You’d certainly have thought so

And I know another PI who owns even more than me! We hold the power. If I sell all my holding you lose a lot of money lol. But dont worry, neither of us are selling anytime soon. I am more than convinced we will hit at least 2 large contracts, hopeful of 3. 10p is where Guy, our CEO receives his bonus and I am very confident he’ll have a great Christmas, as well as myself

Ask price moving up. 2.98p to buy now. They are trying to encourage sellers and discourage buyers. No idea if it’s significant but I’m certainly not giving any of my several million shares

Government are ramping up ‘lateral flow tests’ to 10 million a day. There are only 3 certified lateral flow tests by the U.K. government. The Healgen Test is one of them. We are 50/50 partners in the Healgen test. We have a mkt cap of £6m. Wow

Anyone seen the Sunday Telegraph article? It’s about the U.K. taking 2 tests a week and using a service which sounds very much like COV-ID. Interesting to say the least. Healgen Test is top drawer too

I’d like to think sooner. So many shots on goal. When Guy Meyer said ‘cliff edge in terms of growth‘ I don’t think he was thinking medium or long term

In terms of mkt cap I have a target of £25m which I think is about 9 or 10p. That’s the point at which I will derisk. I’d love it to go higher of course. And as Phil pointed out - Meyer and another chap (CEOs) receive a few £100k at 10p and it continues up to 50p. I really do think 10p will be hit ST. Literally everything is in place to go huge. Exciting times. Good luck all!

“The Healgen rapid test showed excellent sensitivity and specificity.” Results from a scientific study on our Healgen test. It’s the real deal folks (https://www.medrxiv.org/content/10.1101/2020.11.13.20229625v1)

Very well said sir. Couldn’t agree more

‘To be the best out of the 11’ - apologies! Perhaps a little excited. It’s 1 of 3 certified by U.K. government. Our JV has exclusivity to the U.K. Testing is going up massively- CTEA just need to get a deal over the line. ‘Cliff edge in terms of growth’ (CEO) gives me confidence, plus clues of talking to governments in RNSs

Our JV has exclusivity to the Healgen Test in the U.K. it is the best performing test...

A study on COVID-19 lateral-flow immunoassays (LFIAs) for their specificity, sensitivity and ease-of-use by the general public has concluded that Healgen Scientific's (Zhejiang Orient Gene Biotech) COVID-19 IgM/IgG Test to be the best out of eleven LFIAs evaluated. The test has already received US FDA-EUA.

The study carried out by the UK Government's REACT 2 team which has been published in the journal Thorax , is the biggest and most robust study on LFIAs. It analysed 11 LFIAs to evaluate their accuracy and ease of use among NHS workers, comparing them to gold standard lab-based antibody tests.

No wonder you could sell v large quantities above bid today

Any idea the population of The SADC countries? 345 million people. The Afrik-ID partnership could be an absolute monster. Have taken the quote from the CEOs comments from the recent RNS...

David Newman, Chairman and Chief Executive Officer of Afrik-ID, said: "Afrik-ID has been assessing the market for Catenae solutions into the SADC region. With the advent of the Catenae/BHA JV, the growing functionality around the technology and the obvious commercial application into sectors such as mining and telecoms, we are keen to build on the existing agreement and widen it to a full market exploitation, commercialisation and support arrangement based on the new holistic solution."

Worth pointing out that CTEAs JV is not only for coronavirus. COVID-19 has pushed things to this point but as the #CTEA CEO mentioned- the JV with BHA will diversify to test, track & trace viruses & diseases like yellow fever, HIV, TB etc which are rife throughout Africa

Yes they can and they will. Have you watched the proactive interview from 3 weeks ago? There are many many more TB, HIV, yellow fever tests than there are covid tests. Watch the interview, will make you very happy with your investment

I agree Phil, although we won’t need that long. My take is this - if we get a contract with U.K. government then news will come before end of year as the mass increase in testing is for January. If BHA go down the South African route then the vaccine doesn’t work there so it’s all systems go testing wise over there. Then there’s the private companies route - FTSE100 companies type thing. Lots of opportunities and at least 1 of those will hit, otherwise-what’s the point in the JV?!

Also, don’t forget HIV, TB, yellow fever etc for the JV as stated in the proactive interview 3 weeks ago.

AND - worth pointing out the SP was 2.50p BEFORE the JV was announced. Huge